dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Muñoz-Martínez, Sergio |
dc.contributor.author | Forner, Alejandro |
dc.contributor.author | Nault, Jean-Charles |
dc.contributor.author | Sapisochin, Gonzalo |
dc.contributor.author | Rimassa, Lorenza |
dc.contributor.author | Minguez Rosique, Beatriz |
dc.contributor.author | Sapena, Victor |
dc.date.accessioned | 2021-12-27T13:11:19Z |
dc.date.available | 2021-12-27T13:11:19Z |
dc.date.issued | 2021-06 |
dc.identifier.citation | Muñoz-Martínez S, Sapena V, Forner A, Nault JC, Sapisochin G, Rimassa L, et al. Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP Reports. 2021 Jun;3:100260. |
dc.identifier.issn | 2589-5559 |
dc.identifier.uri | https://hdl.handle.net/11351/6731 |
dc.description | Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Assaigs clínics; Càncer de fetge |
dc.description.sponsorship | There was no funding for this study. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | JHEP Reports;3 |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Fetge - Malalties - Diagnòstic |
dc.subject | Pandèmia de COVID-19, 2020- |
dc.subject | Decisió, Presa de |
dc.subject.mesh | Liver Neoplasms |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Clinical Decision-Making |
dc.title | Assessing the impact of COVID-19 on liver cancer management (CERO-19) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.jhepr.2021.100260 |
dc.subject.decs | neoplasias hepáticas |
dc.subject.decs | /diagnóstico |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | toma de decisiones clínicas |
dc.relation.publishversion | https://doi.org/10.1016/j.jhepr.2021.100260 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Muñoz-Martínez S, Sapena V, Forner A] BCLC group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain. [Nault JC] Service d’hépatologie, Hôpital Avicenne, Hôpitaux Universitaires Paris-Seine-Saint-Denis, Assistance-Publique Hôpitaux de Paris, Bobigny, France. Unité de Formation et de Recherche Santé Médecine et Biologie Humaine, Université Paris Nord, Paris, France. Centre de Recherche des Cordeliers, Inserm, Sorbonne Université, Université Paris, INSERM UMR 1138 Functional Genomics of Solid Tumors Laboratory, Paris, France. [Sapisochin G] Abdominal Transplant & HPB Surgical Oncology, University Health Network, Toronto General Hospital, University of Toronto, Toronto, Canada. [Rimassa L] Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center – IRCCS, Rozzano, Milan, Italy. Department of Biomedical Sciences, Humanitas University, Milan, Italy. [Mínguez B] Unitat del Fetge, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Malalties hepàtiques, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 33644725 |
dc.identifier.wos | 000658290100009 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |